Search research articles
Contact Us
Filters
Showing results (151-160 of 210) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2019
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, et al.
The New England Journal of Medicine
|
March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
Jan Cools, Daniel J DeAngelo, Jason Gotlib, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2018
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Jason Gotlib, Aaron T Gerds, Prithviraj Bose, et al.
Cancer Research
|
March 4, 2017
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent, Cem Akin, Karin Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2019
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T Dao, Jason Gotlib, Michael M N Deininger, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
Gregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2016
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Ruben Mesa, Catriona Jamieson, Ravi Bhatia, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
Karl Sotlar, Tracy I George, Philip Kluin, et al.
Leukemia
|
February 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms
Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 6, 2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Michael W Deininger, Neil P Shah, Jessica K Altman, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 210) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2019
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, et al.
The New England Journal of Medicine
|
March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
Jan Cools, Daniel J DeAngelo, Jason Gotlib, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2018
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Jason Gotlib, Aaron T Gerds, Prithviraj Bose, et al.
Cancer Research
|
March 4, 2017
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent, Cem Akin, Karin Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2019
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T Dao, Jason Gotlib, Michael M N Deininger, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
Gregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2016
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Ruben Mesa, Catriona Jamieson, Ravi Bhatia, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
Karl Sotlar, Tracy I George, Philip Kluin, et al.
Leukemia
|
February 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms
Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 6, 2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Michael W Deininger, Neil P Shah, Jessica K Altman, et al.
Page
of 21